Perfios, the Indian B2B fintech SaaS unicorn, reports a 46% surge in FY25 profit, reaching $12.5M, with...
sivam
India's industrial and warehousing stock surpasses 500 million sq ft, driven by robust demand and strategic logistical...
Indian drugmakers launch cheaper semaglutide generics after patent expiry, intensifying competition in the weight-loss market. Affordable options...
Alkem Labs enters India's weight-loss market with Semaglutide injection, offering a cost-effective solution for diabetes and weight...
Rakesh Roshan commends Aditya Dhar for 'Dhurandhar: The Revenge' success. Starring Ranveer Singh, the film marks a...
India directs WhatsApp to block device IDs used in digital arrest scams. New measures to combat fraud...
India considers resuming Iranian oil imports after the US eases sanctions. Asian refiners explore options amid energy...
Indian firms launch generic semaglutide, challenging Novo Nordisk's Ozempic & Wegovy. Affordable access to diabetes & weight...
Dr. Reddy's Laboratories introduces Obeda, a semaglutide injectable, in India, enhancing their diabetes care portfolio. A new...
Dr. Reddy's Laboratories introduces 'Obeda', a semaglutide version for diabetes management in India. Aims to expand its...